These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

424 related articles for article (PubMed ID: 35757923)

  • 41. Development of SARS-CoV-2 animal vaccines using a stable and efficient NDV expression system.
    He L; Zhong J; Li G; Lin Z; Zhao P; Yang C; Wang H; Zhang Y; Yang X; Wang Z
    J Med Virol; 2023 Jan; 95(1):e28237. PubMed ID: 36258299
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A new pharmacological approach based on remdesivir aerosolized administration on SARS-CoV-2 pulmonary inflammation: A possible and rational therapeutic application.
    Contini C; Enrica Gallenga C; Neri G; Maritati M; Conti P
    Med Hypotheses; 2020 Nov; 144():109876. PubMed ID: 32562915
    [TBL] [Abstract][Full Text] [Related]  

  • 43. SARS-CoV-2 pandemic and research gaps: Understanding SARS-CoV-2 interaction with the ACE2 receptor and implications for therapy.
    Datta PK; Liu F; Fischer T; Rappaport J; Qin X
    Theranostics; 2020; 10(16):7448-7464. PubMed ID: 32642005
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Microglia Do Not Restrict SARS-CoV-2 Replication following Infection of the Central Nervous System of K18-Human ACE2 Transgenic Mice.
    Olivarria GM; Cheng Y; Furman S; Pachow C; Hohsfield LA; Smith-Geater C; Miramontes R; Wu J; Burns MS; Tsourmas KI; Stocksdale J; Manlapaz C; Yong WH; Teijaro J; Edwards R; Green KN; Thompson LM; Lane TE
    J Virol; 2022 Feb; 96(4):e0196921. PubMed ID: 34935438
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Investigations on SARS-CoV-2 Susceptibility of Domestic and Wild Animals Using Primary Cell Culture Models Derived from the Upper and Lower Respiratory Tract.
    Färber I; Krüger J; Rocha C; Armando F; von Köckritz-Blickwede M; Pöhlmann S; Braun A; Baumgärtner W; Runft S; Krüger N
    Viruses; 2022 Apr; 14(4):. PubMed ID: 35458558
    [TBL] [Abstract][Full Text] [Related]  

  • 46. COVID-19 basics and vaccine development with a Canadian perspective.
    Liu M; Chen X
    Can J Microbiol; 2021 Feb; 67(2):112-118. PubMed ID: 33136431
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Comparison of the pathogenesis of SARS-CoV-2 infection in K18-hACE2 mouse and Syrian golden hamster models.
    Jeong H; Woo Lee Y; Park IH; Noh H; Kim SH; Kim J; Jeon D; Jang HJ; Oh J; On D; Uhm C; Cho K; Oh H; Yoon S; Seo JS; Kim JJ; Seok SH; Lee YJ; Hong SM; An SH; Yeon Kim S; Kim YB; Hwang JY; Lee HJ; Kim HB; Jeong DG; Song D; Song M; Park MS; Choi KS; Park JW; Seo JY; Yun JW; Shin JS; Lee HY; Nam KT; Seong JK
    Dis Model Mech; 2022 Nov; 15(11):. PubMed ID: 36222118
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Sequential Delivery of Live Attenuated Influenza Vaccine and Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in the Ferret Model Can Reduce SARS-CoV-2 Shedding and Does Not Result in Enhanced Lung Pathology.
    Ryan KA; Schewe KE; Crowe J; Fotheringham SA; Hall Y; Humphreys R; Marriott AC; Paterson J; Rayner E; Salguero FJ; Watson RJ; Whittaker CJ; Carroll MW; Dibben O
    J Infect Dis; 2022 Feb; 225(3):404-412. PubMed ID: 34893851
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Current State of Knowledge about Role of Pets in Zoonotic Transmission of SARS-CoV-2.
    Dróżdż M; Krzyżek P; Dudek B; Makuch S; Janczura A; Paluch E
    Viruses; 2021 Jun; 13(6):. PubMed ID: 34208484
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Comparative tropism, replication kinetics, and cell damage profiling of SARS-CoV-2 and SARS-CoV with implications for clinical manifestations, transmissibility, and laboratory studies of COVID-19: an observational study.
    Chu H; Chan JF; Yuen TT; Shuai H; Yuan S; Wang Y; Hu B; Yip CC; Tsang JO; Huang X; Chai Y; Yang D; Hou Y; Chik KK; Zhang X; Fung AY; Tsoi HW; Cai JP; Chan WM; Ip JD; Chu AW; Zhou J; Lung DC; Kok KH; To KK; Tsang OT; Chan KH; Yuen KY
    Lancet Microbe; 2020 May; 1(1):e14-e23. PubMed ID: 32835326
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Using
    Da Costa CBP; Cruz ACM; Penha JCQ; Castro HC; Da Cunha LER; Ratcliffe NA; Cisne R; Martins FJ
    Expert Opin Drug Discov; 2022 Feb; 17(2):121-137. PubMed ID: 34727803
    [TBL] [Abstract][Full Text] [Related]  

  • 52. SARS-CoV-2 Variant Pathogenesis Following Primary Infection and Reinfection in Syrian Hamsters.
    Plunkard J; Mulka K; Zhou R; Tarwater P; Zhong W; Lowman M; Wong A; Pekosz A; Villano J
    mBio; 2023 Apr; 14(2):e0007823. PubMed ID: 37036339
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Pathophysiology, Transmission, Diagnosis, and Treatment of Coronavirus Disease 2019 (COVID-19): A Review.
    Wiersinga WJ; Rhodes A; Cheng AC; Peacock SJ; Prescott HC
    JAMA; 2020 Aug; 324(8):782-793. PubMed ID: 32648899
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Animal models for SARS-CoV-2 infection and pathology.
    Bi Z; Hong W; Yang J; Lu S; Peng X
    MedComm (2020); 2021 Dec; 2(4):548-568. PubMed ID: 34909757
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Evidence of a wide gap between COVID-19 in humans and animal models: a systematic review.
    Ehaideb SN; Abdullah ML; Abuyassin B; Bouchama A
    Crit Care; 2020 Oct; 24(1):594. PubMed ID: 33023604
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Influenza Infection in Ferrets with SARS-CoV-2 Infection History.
    Vilas Boas de Melo C; Peters F; van Dijken H; Lenz S; van de Ven K; Wijsman L; Gomersbach A; Schouten T; van Kasteren PB; van den Brand J; de Jonge J
    Microbiol Spectr; 2022 Dec; 10(6):e0138622. PubMed ID: 36301107
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Animal models to study the neurological manifestations of the post-COVID-19 condition.
    Usai C; Mateu L; Brander C; Vergara-Alert J; Segalés J
    Lab Anim (NY); 2023 Sep; 52(9):202-210. PubMed ID: 37620562
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Pathogenesis-directed therapy of 2019 novel coronavirus disease.
    Stratton CW; Tang YW; Lu H
    J Med Virol; 2021 Mar; 93(3):1320-1342. PubMed ID: 33073355
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Characterization of Two Heterogeneous Lethal Mouse-Adapted SARS-CoV-2 Variants Recapitulating Representative Aspects of Human COVID-19.
    Yan F; Li E; Wang T; Li Y; Liu J; Wang W; Qin T; Su R; Pei H; Wang S; Feng N; Zhao Y; Yang S; Xia X; Gao Y
    Front Immunol; 2022; 13():821664. PubMed ID: 35197985
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Sequential infection with H1N1 and SARS-CoV-2 aggravated COVID-19 pathogenesis in a mammalian model, and co-vaccination as an effective method of prevention of COVID-19 and influenza.
    Bao L; Deng W; Qi F; Lv Q; Song Z; Liu J; Gao H; Wei Q; Yu P; Xu Y; Qu Y; Li F; Xue J; Gong S; Liu M; Wang G; Wang S; Zhao B; Cong B; Qin C
    Signal Transduct Target Ther; 2021 May; 6(1):200. PubMed ID: 34016949
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.